EV/EBITDA:
N/ASummary
- BPMC EV/EBITDA is not available.
Performance
BPMC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
BPMC EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 6M6 Months | - | - | - |
| 1Y1 Year | - | - | - |
| 5Y5 Years | - | - | - |
BPMC EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | ||||
| 3M | 3-Month | -127.95 | -127.95 | ||
| 6M | 6-Month | -83.17 | -127.95 | ||
| 1Y | 1-Year | 388.66 | -134.24 | ||
| 3Y | 3-Year | 388.66 | -134.24 | ||
| 5Y | 5-Year | 388.66 | -134.24 | ||
| All-Time | All-Time | 388.66 | -134.24 |
BPMC EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 294.56(+2387.0%) |
| 2023 | -12.88(-181.2%) |
| 2022 | -4.58(+51.8%) |
| 2021 | -9.51(-152.6%) |
| 2020 | 18.08(+263.8%) |
| Date | Value |
|---|---|
| 2019 | -11.04(-16.2%) |
| 2018 | -9.50(+50.8%) |
| 2017 | -19.29(-54.2%) |
| 2016 | -12.51(-16.3%) |
| 2015 | -10.76 |
FAQ
- What is the all-time high EV/EBITDA for Blueprint Medicines Corporation?
What is the all-time high EV/EBITDA for Blueprint Medicines Corporation?
Blueprint Medicines Corporation all-time high EV/EBITDA is 388.66